Lynda Charters

Elena Biffi, OD, MSc, FAAO, dives into AMD, a multifactorial disease that requires a multimodal diagnostic imaging approach.

Correcting refractive errors in infants and toddlers differs from that in adults. Ida Chung, OD, MS, FCOVD, FAAO, walks optometrists through the pearls and pitfalls of prescribing for this patient population.

At AOA 2022, Rebecca Wartman, OD, and Harvey Richmond, OD, discuss how eye care practitioners can properly and efficiently establish a telehealth program in their practice.

Mitch Ibach, OD, and Damon Dierker, OD, explore how the current landscape in cataract surgery shows an upward swing in the number of surgeries that are being performed in increasingly younger patients by an increasingly small number of surgeons.

Denise Valenti, OD, advises on why driving under the influence of marijuana is not without visual consequences.

All data were collected in the Fight Retinal Blindness! Registry.

Researchers in Poland investigated the presence and duration of ocular symptoms of patients with symptomatic COVID-19 infections.

Researchers report that the incidence of retinal vein occlusions increased in the 6 months following COVID-19 diagnosis.

A prototype of a visually-guided hearing aid (VGHA) designed at Boston University of a the formed beam is manipulated by eye gaze to improve the ability of users of the technology to better focus on one sound despite the presence of nearby competing sounds.

A look at the current and future landscape of treatment options for this age-related condition.

Researchers are attempting to determine how pediatric visual impairment caused by damage to the brain is different from visual impairment at the level of the eye.

Researchers found that patients with nAMD lost vision as a result of the lockdown and reduced number of treatments during the COVID-19 pandemic.

At-home visual acuity tests compare favorably within 1 line of vision to VA measurements performed during a standard office visit.

Vascular density might be a biomarker for microvascular abnormalities following COVID-19

Acute infection did not impact the ability to obtain reliable test results

Researchers report a recombinant biologic derived from blood-feeding ticks may be a potential treatment for allergic eye disease

The National Institute for Health and Care Excellences announced SLT as the new primary form of glaucoma intervention.

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly

Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.

Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.

Clinical pearls on giant cell arteritis (GCA) and optic neuritis

Tools and therapies for dry eye with contact lens wear

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

Optometrists at the forefront of ocular basal cell and squamous cell carcinomas

OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.

SARS-CoV-2 may target lacrimal gland tissue and manifest as chronic inflammation

Latest innovations within the presbyopic landscape are proving game-changers for better patient treatment.

Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.